Recent research has found a new way to make graphene that adds structural defects to improve the performance of the material that could have benefits across a range of applications—from sensors and ...
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN) has signed an exclusive licensing agreement with South Korea’s Kwangdong Pharmaceutical Co., Ltd. for the rights to develop and commercialize OCU400, Ocugen’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback